ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Eneabba G Def

Eneabba G Def (ENBN)

0.00
0.00
(0.00%)
Closed August 19 2:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ENBN Latest News

Enterprise National Bank Announces Restatement

KENILWORTH, N.J., Dec. 17 /PRNewswire-FirstCall/ -- Enterprise National Bank NJ (OTC:ENBN) (BULLETIN BOARD: ENBN) announced a restatement of its results of operations for the three and nine...

Enterprise National Bank N.J. Announces Third Quarter Earnings, Nine Month Results

KENILWORTH, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net profit of $68 thousand, or $0.04 per share, for...

Update: Enterprise Bank Announces Second Quarter Results

KENILWORTH, N.J., July 23 /PRNewswire-FirstCall/ -- The following is an update to yesterday's press release for Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN...

Enterprise Bank Announces Second Quarter Results

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $43 thousand, or $(0.02) per share, for...

Enterprise Bank Announces First Quarter Results

KENILWORTH, N.J., April 11 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $121 thousand, or $(0.07) per share, for...

Enterprise National Bank N.J. Announces Fourth Quarter and Year End Results

KENILWORTH, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $26 thousand, or $0.01 per share, for the...

Enterprise National Bank N.J.

Enterprise Bank Announces Third Quarter Results KENILWORTH, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN.OB) (BULLETIN BOARD: ENBN.OB) reported a...

Enterprise Bank Announces Second Quarter Results

KENILWORTH, N.J., July 23 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $162 thousand, or $(0.09) per share, for...

Enterprise Bank Announces First Quarter Results

KENILWORTH, N.J., May 1 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $164 thousand, or $(0.09) per share, for...

Enterprise National Bank N.J. Announces Fourth Quarter and Year End Results

KENILWORTH, N.J., Jan. 23 /PRNewswire-FirstCall/ -- Enterprise National Bank N.J. (the "Bank") (OTC:ENBN) (BULLETIN BOARD: ENBN) reported a net loss of $161 thousand, or $0.09 per share, for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VTXOAVertex Minerals Ltd
AUD 0.02
(300.00%)
50k
ARNOAldoro Resources Limited
AUD 0.028
(180.00%)
15k
ACMOAAustralian Critical Minerals Ltd
AUD 0.02
(150.00%)
312.2k
LRVOLarvotto Resources Ltd
AUD 0.035
(105.88%)
1.02M
MTMOMTM Critical Metals Ltd
AUD 0.002
(100.00%)
2.33M
1CGOOne Click Group Ltd
AUD 0.001
(-66.67%)
200k
EUROBEuropean Lithium Limited
AUD 0.001
(-50.00%)
500k
ARVOCArtemis Resources Limited
AUD 0.002
(-33.33%)
8.06M
SI6Si6 Metals Limited
AUD 0.001
(-33.33%)
260.33k
IPTOImpact Minerals Ltd
AUD 0.002
(-33.33%)
33.33k
LRSLatin Resources Ltd
AUD 0.19
(0.00%)
52.94M
SVLSilver Mines Limited
AUD 0.078
(-15.22%)
48.76M
NAGNagambie Resources Limited
AUD 0.015
(36.36%)
44.25M
JAVJavelin Minerals Ltd
AUD 0.002
(0.00%)
42.51M
LRVLarvotto Resources Ltd
AUD 0.24
(33.33%)
26.49M

Discussion

View Full Feed
Viewmont Viewmont 10 seconds ago
https://x.com/ThePennyLounge/status/1825546246876184996
IJJP
drugmanrx drugmanrx 20 seconds ago
Deal entered Feb 27 2024 , not 8ked to 4/1/2024, IMO someone else other than SAPX is making the calls.
SAPX
LuckyLovie LuckyLovie 20 seconds ago
This may tie Ronny in the terrible ²'s this week..

Whenever you see promoters asking for tips to bullystick and mess ups on earnings and weird excuses & DELAYS. & a freaking anthem song which does soundpretty good ...it is B.O.G.U.S.
IGPK
i_like_bb_stock i_like_bb_stock 36 seconds ago
Yep
ASII
srinsocal srinsocal 59 seconds ago
Another 10 million Share Buy Hits the Tape

The 2 Ask down to 88 million shares.

Total Volume at 31 million shares, highest in last 58 days.
BIEL
Lokotony Lokotony 1 minute ago
Like they are saving somebody!!!!!
NSAV
bucks2pennies bucks2pennies 1 minute ago
If I understand you post correctly, Vex, I see a mutual understanding here. My early posts are directed towards improving the platform. What I hope to achieve early on in this VIP forum is to have a meeting of the minds. Mutual, NOT my way or yours. ALL who post here. We all seek gain of knowl
GTF GTF 1 minute ago
AI search reveals Zelda is directed by Ron Howard.
PSRU
jesster64 jesster64 1 minute ago
Only 2 reasons why keytruda/dcvax combo trial results are being kept quiet. 1, its all BS, smoke and mirrors. 2. Waiting for UK approval for merck B/O. Keytruda patent expires in less than 4 years. dcvax combo patent would extend keytruda cash cow another 12 years at least. I would gladly take a 20
NWBO
€LL-$G7$ €LL-$G7$ 2 minutes ago
Yeah of course. You are soooo right
Buy niw before it gets too high
GGSM
demonsmith demonsmith 2 minutes ago
I pick up 2 mil more at 0.0013
ASII
dukeb dukeb 2 minutes ago
Well, it's possible that someone qualified to do a proper financial disclosure would not go along with the mirage that Scozz wants the world to see.

CPAs tend to want to protect their licenses.
KEGS
surfkast surfkast 2 minutes ago
Pathetic!
GVSI
ProfitScout ProfitScout 2 minutes ago
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update

Company is now funded for and focused on New Drug Applications (NDAs) for NRX-100 (ketamine) and NRX-101

Audit of HOPE Therapeutics
NRXP
misterfishman misterfishman 2 minutes ago
well done bro. well done indeed.
IGPK
gp22 gp22 2 minutes ago
MONKEY POX STOCK REPORT: $AEMD @ .50s seeing $VRAX, $GOVX and $APDN cash flowing in to $AEMD. Low floater and cash rich.
AEMD APDN GOVX
i_like_bb_stock i_like_bb_stock 3 minutes ago
If you’re tired of basher hub message me can’t deal with it anymore
ASII
BeachBum BeachBum 3 minutes ago
I’m 10 of those. Lol
IDVV
gp22 gp22 3 minutes ago
MONKEY POX STOCK REPORT: $AEMD @ .50s seeing $VRAX, $GOVX and $APDN cash flowing in to $AEMD. Low floater and cash rich.
AEMD APDN GOVX
Value_Investor Value_Investor 3 minutes ago
TNXP has bounced Up 110.3% today after Good News --- from $0.4021 to $0.8456! Last January it did Quickly surge 5.2-Bagger to Pre-R/S's $1.456 from Pre-R/S's $0.28 --- see the first chart below!

This Hidden Gem is also at Hyper Oversold status --- from May 17's high $6.72 to Super-Rid
TNXP
jimr1717 jimr1717 3 minutes ago
They are currently burning all of the bagasse to make electric for the generator that supplies power to the share printer.
After the next 100 million shares there won’t be much left
IFUS
cojoboy cojoboy 3 minutes ago
Good for you bro..!!
IGPK
BeachBum BeachBum 3 minutes ago
It’s a pre revenue web site with a stupid IP mark in Waygers with a video that references Wagers which is not their domain and IP. Did they even look at the video and wonder if displaying winnerwagers was going to be overlooked? Winnerswagers is better but isn’t theirs unless I’m missing something.
IDVV
ProfitScout ProfitScout 4 minutes ago
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update

Company is now funded for and focused on New Drug Applications (NDAs) for NRX-100 (ketamine) and NRX-101

Audit of HOPE Therapeutics
NRXP